SECsense Logo

Biogen Inc. 8-K Report: Key Corporate Updates as of July 31, 2025

$BIIB
Form 8-K
Filed on: 2025-07-31
Source
Biogen Inc. 8-K Report: Key Corporate Updates as of July 31, 2025

Here is the key information extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Biogen Inc.
  • State of Incorporation: Delaware (DE)
  • SEC CIK: 0000875045
  • IRS Employer Identification Number (EIN): 33-0112644
  • Address: 225 Binney Street, Cambridge, MA 02142
  • Phone Number: 617-679-2000
  1. Filing Information:
  • Filing Type: 8-K (current report used to disclose major events that shareholders should know about)
  • Filing Date: July 31, 2025
  1. Stock Information:
  • Common Stock: $0.0005 par value
  • Ticker Symbol: BIIB
  • Exchange: NASDAQ
  1. Period of Report:
  • Report Date: July 31, 2025 (this appears to be both the start and end date for the reported period)

Insights:

  • Biogen Inc. is providing a current report (8-K) which typically indicates significant corporate events or changes, suggesting there may be important updates or disclosures for investors.
  • The company's common stock is traded on NASDAQ under the ticker symbol BIIB, which is relevant for shareholders and potential investors looking to track market performance.
  • The report specifies a single-day report date, indicating that the information disclosed may pertain to an event or circumstance occurring on that specific date rather than over a longer reporting period.

This financial report section primarily serves to inform stakeholders about key corporate updates and operational details relevant to Biogen Inc. as of the end date specified.